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Summary
The terminal step in cytokinesis, called abscission,
requires resolution of the membrane connection be-
tween two prospective daughter cells. Our previous
studies demonstrated that the coiled-coil protein
centriolin localized to the midbody during cytokinesis
and was required for abscission. Here we show that
centriolin interacts with proteins of vesicle-targeting
exocyst complexes and vesicle-fusion SNARE com-
plexes. These complexes require centriolin for local-
ization to a unique midbody-ring structure, and dis-
ruption of either complex inhibits abscission. Exocyst
disruption induces accumulation of v-SNARE-con-
taining vesicles at the midbody ring. In control cells,
these v-SNARE vesicles colocalize with a GFP-tagged
secreted polypeptide. The vesicles move to the mid-
body ring asymmetrically from one prospective
daughter cell; the GFP signal is rapidly lost, suggest-
ing membrane fusion; and subsequently the cell
cleaves at the site of vesicle delivery/fusion. We pro-
pose that centriolin anchors protein complexes re-
quired for vesicle targeting and fusion and integrates
membrane-vesicle fusion with abscission.
Introduction
Cytokinesis is a fundamental process that results in di-
vision of a single cell with replicated DNA into two
daughters with identical genomic composition (see
(Glotzer, 2001, 2005; Guertin et al., 2002). Early events
in animal cell cytokinesis include assembly and con-
traction of the actomyosin ring to form the cleavage
furrow. Continued furrowing results in constriction of
the plasma membrane to form a narrow cytoplasmic
bridge between the two nascent daughter cells. Within
this intercellular bridge are bundled microtubules and a
multitude of proteins that together form the midbody.
In a poorly understood final step called abscission, the*Correspondence: stephen.doxsey@umassmed.edu
3Present address: Department of Genetics and Tumor Cell Biology,
St. Jude Children’s Research Hospital, Memphis, Tennessee,
38105.cell cleaves at the intercellular bridge to form two
daughter cells.
Membrane trafficking is required for late stages of
cytokinesis (Albertson et al., 2005; Finger and White,
2002; Jurgens, 2005; Papoulas et al., 2004; Strickland
and Burgess, 2004). In C. elegans embryos, inhibition
of Golgi secretion by brefeldin A (BFA) resulted in late-
stage cytokinesis defects (Skop et al., 2001). More
recent studies in mammalian cells using dominant-
negative approaches showed that the membrane-
fusion-inducing SNARE components, syntaxin-2 and
endobrevin/VAMP8, are required for a final step in cell
cleavage (Low et al., 2003). Endocytic traffic also plays
a role in cytokinesis. Recycling endosomes and associ-
ated components localize to the midbody and are re-
quired for cell cleavage (Monzo et al., 2005; Wilson et
al., 2005; Thompson et al., 2002). However, little is
known about the spatial and temporal control of dy-
namic membrane compartments and molecules during
abscission or how these activities are coordinated to
achieve cell cleavage.
The role of membrane-vesicle-tethering exocyst
complexes in animal cell abscission is poorly under-
stood. The exocyst is a multiprotein complex that tar-
gets secretory vesicles to distinct sites on the plasma
membrane. In the budding yeast S. cerevisiae, exocyst
components localize to the mother-bud neck, the site
of cytokinesis (Finger et al., 1998; Mondesert et al.,
1997). Exocyst disruption results in accumulation of
vesicles at this site (Salminen and Novick, 1989) and
impairs actomyosin-ring contraction and cell cleavage
(Dobbelaere and Barral, 2004; Verplank and Li, 2005).
In the fission yeast S. pombe, exocyst components lo-
calize to the actomyosin ring (Wang et al., 2002). Mu-
tants for the exocyst component Sec8 accumulate 100
nm “presumptive” secretory vesicles near the division
septum and cannot complete extracellular separation
of the two daughter cells. A screen for cytokinesis mu-
tants in Drosophila melanogaster identified the exocyst
component sec5 (Echard et al., 2004), and proteomic
analysis of the midbody in mammalian cells showed
that the exocyst protein sec3 is at the midbody (Skop
et al., 2004). Mammalian exocyst components are in-
volved in secretion in polarized epithelial cells (Yeaman
et al., 2004) and localize to the midbody (Skop et al.,
2004; Wilson et al., 2005), but the function of the exo-
cyst during cytokinesis is unclear.
Components of membrane-vesicle-tethering and
-fusion complexes have been identified in some organ-
isms and linked to cytokinesis, but the pathway that
integrates these complexes with vesicle trafficking dur-
ing cell cleavage is unknown. Little is known about how
SNAREs and the exocyst are anchored at the midbody
or how they modulate membrane-vesicle organization
and fusion to coordinate abscission. Moreover, the ori-
gin and dynamics of membrane compartments in-
volved in abscission have not been investigated. In this
manuscript, we describe a multistep pathway for ab-
scission that requires a scaffold protein to anchor
Cell
76SNARE and exocyst complexes at a unique midbody
site and also requires asymmetric transport and fusion
of secretory vesicles at this site.
Results
Centriolin Is Part of a Ring-like Structure
at the Central Midbody during Cytokinesis
We previously showed that centriolin localized to the
midbody during cytokinesis (Gromley et al., 2003).
Using high-resolution deconvolution microscopy, we
now demonstrate that centriolin is part of a unique ring-
like structure within the central portion of the midbody,
which we call the midbody ring (observed in w75% of
all telophase cells, Figures 1A–1C). The midbody ring
was 1.5–2 m in diameter (Figure 1C), contained γ-tubulin
(Figure 1D), and colocalized with the phase-dense
Flemming body (Figure 1B, inset) (Paweletz, 1967). In
fact, high-magnification phase-contrast imaging re-
vealed that the Flemming body was organized into a
ring-like structure (Figure 1E). The midbody ring was
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uFigure 1. Centriolin Localizes to a Midbody Ring
(A) Immunofluorescence/phase image of HeLa cell during cytokinesis showing the phase-dense Flemming body within the larger diameter of
the plasma membrane (arrowheads in [B]).
(B and C). Boxed region enlarged with insets (B) to show the centriolin ring (Centr, enlarged in [C]) as part of the Flemming body (phase) and
flanked bilaterally by Aurora B (Aur B).
(D) γ-tubulin localizes to the midbody ring (inset, Flemming body) and sites of presumed microtubule minus ends (arrowheads).
(E) The Flemming body forms a ring.
(F) GFP-tagged GAPCenA localizes to the midbody ring and is highly dynamic (time in s).
(G–I) MKLP-1 localizes to the midbody ring (G) and, upon depletion, mislocalizes centriolin from the midbody (I). Immunoblots (IB) from cells
treated with siRNAs targeting MKLP-1 or lamin A/C (control) (H). γ-tubulin, loading control. Scale bars in (A), 10 m; (B), 5 m; (C), (E), and
(G), 1 m.lanked by Aurora B kinase, which colocalized with
icrotubules on either side of the ring (Figure 1B, in-
et). Several other proteins localized to the midbody
ing including ectopically expressed GFP-GAPCenA, a
TPase-activating protein previously shown to localize
o centrosomes (Cuif et al., 1999). Time-lapse imaging
f GFP-GAPCenA and other proteins in living cells
howed that the midbody ring was dynamic, moving
etween cells and tipping from side to side to reveal
he ring structure (Figure 1F; see also Movie S1 in the
upplemental Data available with this article online). In
ddition, midbody-ring localization of GFP-GAPCenA
onfirmed the ring structure seen by immunofluores-
ence microscopy and demonstrated that there were
o antibody penetration problems in this midbody re-
ion as seen for other antigens (Saxton and McIntosh,
987). The midbody ring was distinct from the actomy-
sin ring and did not change in diameter during cytoki-
esis (Figures 1A and 1B). It appeared during the early
tages of actomyosin-ring constriction and persisted
ntil after cell cleavage (see below).
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ZEN-4 (Figure 1G) and MgcRacGAP/CYK-4 (data not
shown) also localized to the midbody ring and ap-
peared earlier than centriolin during actomyosin-ring
constriction. Depletion of MKLP-1 by RNAi to 18% of
control levels (n = 2 experiments) prevented recruitment
of centriolin to the ring (Figures 1H and 1I). In contrast,
depletion of centriolin had no effect on the localization
of MKLP-1 or MgcRacGAP (data not shown). These
data suggested that centralspindlin anchored centriolin
to the midbody ring.Figure 2. Centriolin Interacts with Exocyst Components and Snapin
(A) Gel filtration (Superose 6) using MDCK cell lysates shows that centriolin coelutes with peak exocyst fractions (top). Immunoprecipitation
(IP) of sec8 coprecipitates centriolin. Graph, total protein profile; markers a–e are indicated.
(B) Following isopycnic centrifugation (iodixanol), centriolin comigrates in peak fractions containing sec8 (upper panels). Graph shows sec8
levels, iodixanol density, and total protein.
(C) Immunoprecipitation (IP) of Nud1-DBD (DBD antibody) pulls down sec15-AD (left). DBD, DNA binding domain; AD, activation domain;
Con, control beads; Lys, lysate.
(D) Endogenous exocyst components coimmunoprecipitate with endogenous centriolin (Cen IP).
(E) Endogenous centriolin immunoprecipitates (Cen IP) overexpressed His6-tagged snapin.Centriolin Interacts with the Exocyst Complex and
the SNARE-Associated Protein Snapin and Is in
Membrane-Associated Cytoplasmic Fractions
To determine the molecular function of centriolin in cy-
tokinesis, we performed a yeast two-hybrid screen
using a 120 amino acid domain of centriolin that is re-
quired for the cytokinesis function of centriolin and
shares homology with budding- and fission-yeast
genes (Nud1/Cdc11) involved in cytokinesis and mitotic
exit (Gromley et al., 2003). A screen of approximately
12 million clones from a human testis cDNA library
Cell
78yielded two potential interacting proteins: sec15, a
member of the exocyst complex, and snapin, a SNARE-
associated protein.
Additional biochemical analysis confirmed the yeast
two-hybrid interactions and demonstrated that centrio-
lin was in a large complex associated with membranes
(Figure 2). The centriolin Nud1 domain fused to the DNA
binding domain (DBD) and sec15 fused to the activa-
tion domain (AD) were coexpressed in the same yeast
cells. Immunoprecipitation of the Nud1 fusion protein
effectively coprecipitated the sec15 fusion protein (Fig-
ure 2C). To test whether other members of the exocyst
complex were bound to centriolin, we immunoprecipi-
tated endogenous centriolin from HeLa cell lysates with
affinity-purified centriolin antibodies and showed that
sec8 and sec5 coprecipitated (Figure 2D). Gel filtration
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fFigure 3. Exocyst Localization to the Midbody Ring Is Centriolin Dependent
(A) Immunofluorescence images of exocyst components (green) costained with centriolin antibodies (panel 1) or with anti-α-tubulin antibody
(red) to visualize microtubules (MTs, panels 2–6). Panel 1 inset: top, sec8; bottom, centriolin.
(B) Cells depleted of centriolin lack midbody-associated exocyst. Images labeled as in A1–A5; B1 inset, Flemming body. Graph, percentage
of midbodies (MB) without (w/o) sec8 signal following treatment with siRNAs targeting lamin A/C or centriolin; other cells have reduced levels
(see text).
(C) siRNA depletion of sec5 disrupts the exocyst from midbodies costained with two exocyst proteins (C1 inset, phase) or one exocyst protein
and microtubules (C2–C3). Graph, percentage of midbodies (MB) lacking sec5 staining in cells treated with lamin A/C or sec5 siRNAs.
(D) Exocyst disruption by siRNAs does not affect centriolin midbody localization. Graph, percentage of midbodies (MB) lacking centriolin
stain following treatment of indicated siRNAs. Scale bar equals 1 m (all panels).
(E) Immunoblots showing reduction of proteins targeted by siRNAs. γ-tubulin (γ-tub), loading control. Cen, centriolin.experiments (Superose 6) using MDCK cell lysatesemonstrated that centriolin coeluted with fractions
ontaining the exocyst complex (detected with anti-
odies to sec8 and sec3, Figure 2A). Centriolin was
luted as a single peak that overlapped with peaks of
ec3 and sec8. We next asked if centriolin coimmuno-
recipitated with the exocyst. Antibodies to sec8 were
dded to each of the fractions from the gel filtration
olumn, and immune complexes were collected and
robed with affinity-purified centriolin antibodies as de-
cribed (Gromley et al., 2003). Centriolin was found only
n fractions containing exocyst components (Figure
A). The centriolin-containing fractions eluted earlier
han the peak of sec 3 or sec8, suggesting that the
xocyst fraction to which centriolin was bound was dif-
erent from the cytosolic and lateral plasma-membrane
ractions of the exocyst (Yeaman et al., 2004). The exo-
cyst-centriolin fractions did not cofractionate with the
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79bulk of the cellular protein and eluted considerably
earlier than thyroglobulin (MW 669,000) suggesting it
was part of a large complex.
Since the exocyst associates with membrane vesi-
cles, we next tested whether centriolin was also pres-
ent in membranous fractions. Cell homogenates were
prepared in the absence of detergent and underlain at
the bottom of linear iodixanol gradients. Isopycnic cen-
trifugation was performed, and fractions were probed
for both centriolin and the exocyst component sec8.
Centriolin “floated up” to fractions lighter than the cyto-
sol having a buoyant density of δ w 1.14 g/ml (Figure
2B). The centriolin peak cofractionated with a major
peak of Sec8 that was slightly less dense than the junc-
tion-associated peak of Sec8 described previously in
confluent MDCK cells (δ w 1.16 g/ml; Yeaman et al.,
2004). Little to no centriolin was observed at other posi-
tions in the gradient or in the major protein peak, sug-
gesting that most if not all centriolin was associated
with membranes. Taken together, the density gradient,
immunoprecipitation, and chromatography data sup-
port the conclusion that centriolin associates with the
exocyst in a very large complex bound to cellular mem-
branes. The yeast two-hybrid interaction between
centriolin and the low-abundance protein snapin was
confirmed by showing that endogenous centriolin
coimmunoprecipitated a His6-tagged snapin fusion
protein expressed in HeLa cells (Figure 2E) and by the
centriolin-dependent midbody localization of snapin
(see below).
The Exocyst Complex Colocalizes with Centriolin
at the Midbody Ring
Further support for the centriolin-exocyst interaction
was obtained by showing that exocyst-complex com-Figure 4. Exocyst Disruption Induces Cytokinesis Defects
(A) Time-lapse images of a HeLa cell treated with lamin A/C siRNAs showing a mitotic cell entering mitosis (arrow), forming a cleavage furrow,
and cleaving into two separate cells in 3 hr. Time, hr:min.
(B) A cell depleted of sec5 enters mitosis (arrow), forms a cleavage furrow with normal timing (w50 min), and remains interconnected by a
thin intercellular bridge for over 17 hr (panels 1:50 through 17:05).
(C) Graph shows percentage of mitotic cells that fail cytokinesis; many others are delayed (see text).ponents localized to the midbody ring with centriolin.HeLa cells were colabeled with antibodies against one
of several exocyst components (sec3, sec5, sec8,
sec15, exo70, or exo84) and either microtubules or
centriolin (Figure 3A). We found that all these exocyst
components localized to the midbody ring during cyto-
kinesis and formed a ring-like structure similar to that
seen for centriolin. In fact, double-stained images re-
vealed considerable overlap between sec8 and centrio-
lin, indicating that they were part of the same structure
(Figure 3A, panel 1). We also showed that a myc-tagged
form of sec8 localized to the midbody ring when ex-
pressed in HeLa cells (Figure S1), confirming the local-
ization seen with antibodies directed to the endoge-
nous protein.
Midbody Localization of the Exocyst Is Disrupted
in Cells Depleted of Centriolin
We next tested whether centriolin was required for mid-
body-ring localization of the exocyst. siRNA-mediated
depletion of centriolin resulted a in w70% reduction in
centriolin protein levels and complete loss of midbody
staining in 24% of cells compared with control cells
treated with lamin siRNA (Figures 3B and 3E). Immuno-
fluorescence quantification of midbody signals per-
formed as in our previous studies (Gromley et al., 2003)
demonstrated that many of the remaining centriolin-
depleted cells had lower levels of midbody staining
than controls (48%, n = 23 cells), bringing the total per-
centage of midbody depleted cells to 72%. Cells that
lacked detectable midbody-associated centriolin usu-
ally lacked midbody labeling of sec8 (10/10, Figure 3B,
panels 1 and 6). Although other exocyst components
could not be costained with centriolin because all were
detected with rabbit antibodies like centriolin, all were
lost from or reduced at midbodies in centriolin-
depleted cells (Figure 3B, panels 2–5). For example,
Cell
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olin-depleted cells (n = 9 cells) or had levels below the
lowest control midbody staining in 42% of centriolin-
depleted cells (n = 19 cells). Significant reduction in
midbody staining of centriolin and other exocyst com-
ponents was observed with a second siRNA targeting
a different centriolin sequence (Gromley et al., 2003)
(data not shown).
To test whether centriolin was dependent on the exo-
cyst complex for localization to the midbody, we initially
targeted sec5 for siRNA depletion. Recent studies
showed that mutants of sec5 in D. melanogaster dis-
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sFigure 5. Centriolin siRNA Mislocalizes Midbody-Ring-Associated SNAREs and Snapin, which Disrupts Cytokinesis When Depleted
(A) Endobrevin/VAMP8 (1) localizes adjacent to the midbody ring when snapin is on the ring (2). Later, when the midbody diameter is thin
(0.5–1 m), endobrevin/VAMP8 and syntaxin-2 localize to the ring (3 and 4).
(B) Centriolin-depleted cell shows loss of snapin from the midbody ring (green). Graph, percentage of midbodies lacking snapin after siRNA
depletion of proteins.
(C) Centriolin-depleted cells lose SNARE proteins from the midbody ring. Graph, percentage of midbodies lacking endobrevin/VAMP8 staining
after indicated siRNAs treatments. Endo, endobrevin.
(D) Snapin-depleted cells show loss of snapin from the midbody ring. Graph, percentage of midbodies lacking snapin after indicated siRNA
treatments.
(E) A snapin-depleted cell in cytokinesis (0) remains connected by a thin intercellular bridge for >17 hr before separating (20:25) (time, hr:min).
Graph, percentage of mitotic cells that failed cytokinesis.upted exocyst function (Murthy and Schwarz, 2004)
nd that RNAi-mediated depletion of sec5 inhibited ex-
cyst-dependent processes in vertebrate cells (Prigent
t al., 2003). We found that depletion of sec5 resulted
n loss of midbody-associated sec5 as well as other
xocyst components, including sec3, sec8, and sec15
Figures 3C and 3E). These results show that sec5 de-
letion disrupts midbody-ring localization of the exo-
yst. In contrast, neither sec5 nor sec8 loss from the
idbody affected the association of centriolin with the
idbody ring (Figures 3D and 3E). These data demon-
trate that centriolin is required for midbody localiza-
Secretory-Vesicle Machinery Mediates Abscission
81Figure 6. Disruption of the Exocyst Results
in Accumulation of Secretory Vesicles at the
Midbody Ring
(A) A mitotic cell (0, arrow) treated with BFA
exits mitosis and forms a cleavage furrow
with normal timing but arrests with a thin in-
tercellular bridge that connects the two
daughters (panels 2:35 through 6:45).
(B) sec5 siRNA-treated cells accumulate en-
dobrevin/VAMP8-containing vesicle-like struc-
tures (arrows) at the Flemming body (arrow-
head, panel 2). Dotted lines, plasma
membrane. Graph, percentage of cells with
endobrevin/VAMP8 vesicles at the midbody
following indicated siRNA treatments. Scale
bars, 2 m.
(C) Endobrevin/VAMP8 (green) localizes to
luminal-GFP secretory vesicles (red). Box at
midbody is enlarged in insets. Endo, endo-
brevin/VAMP8.tion of the exocyst, while localization of centriolin ap-
pears to be independent of the exocyst.
Disruption of the Exocyst Causes Failure
at the Final Stages of Cytokinesis
Localization of the exocyst to the midbody and its in-
teraction with centriolin suggested that the complex
might play a role in cytokinesis. To examine this, we
disrupted the midbody-associated exocyst using siRNAs
targeting sec5 and examined cytokinesis by time-lapse
imaging over a 20 hr time period. We found that over
half the cells exhibited severe cytokinesis defects, in-
cluding failure in the final abscission step (42%, Figures
4B and 4C, Movie S3) and delays during cytokinesis
(24%, n = 18) compared with control lamin siRNA-
treated cells (Figures 4A and 4C, Movie S2). Some cells
remained interconnected by thin cytoplasmic bridges
(Figure 4B, panel 17:05 and Movie S3) and sometimes
entered one or more additional rounds of mitosis while
still connected to their partner cells. Sec5-depleted
cells viewed for an additional 24 hr showed a similar
level of cytokinesis defects (data not shown), suggest-
ing that nearly all cells in the culture experienced cyto-
kinesis problems over time. Cytokinesis defects werealso observed when the exocyst was disrupted by
siRNA depletion of sec15 and sec8 (data not shown).
Cells remained healthy, as no differences in cell mor-
phology or mitochondrial function were observed.
These data show that disruption of the exocyst pro-
duces late-stage cytokinesis defects similar to centrio-
lin (Gromley et al., 2003) and demonstrates a require-
ment for the exocyst in the final stages of animal cell
cytokinesis.
Snapin and SNARE Components Localize to the
Midbody Ring in a Centriolin-Dependent Manner
Snapin was originally considered to be a neuron-spe-
cific protein, but recent studies demonstrated that it is
also expressed in nonneuronal cells (Buxton et al.,
2003). Snapin may facilitate assembly of SNARE com-
plexes and may define a limiting step in vesicle fusion
mediated by PKA phosphorylation (Chheda et al.,
2001). Although the role of snapin in neurotransmission
has been questioned (Vites et al., 2004), recent results
indicate that it is essential for this process (Thakur et
al., 2004). The role of snapin in cytokinesis is currently
unknown. Using previously characterized antibodies to
snapin (Thakur et al., 2004), we demonstrated that the
Cell
82Figure 7. Asymmetric Delivery of Secretory Vesicles to One Side of the Flemming Body Is Followed by Abscission at This Site
(A) A dividing HeLa cell expressing luminal GFP accumulates secretory vesicles on one side of the Flemming body (arrows in 2 and 3, inset).
In panel 1, most luminal-GFP signal is in Golgi complexes (G1 and G2). The signal appears transiently at one side of the midbody (2 and 3,
arrows; Movie S5) and is lost, although Golgi signal remains (4). Scale bar in panel 1, 10 m.
(B) Higher-magnification images of another cell (see Movie S6) showing unidirectional delivery of luminal-GFP-containing vesicles from one
nascent daughter cell to one side of the Flemming body (arrowhead). GFP vesicles move to the Flemming body from the cell on the right
(1:18 and 1:40, arrows; see Movie S6) and quickly disappear (1:52), presumably due to vesicle fusion with the plasma membrane and diffusion
of the signal into the extracellular space. Phase and GFP signals are overlaid. Time, hr:min. Scale bar in panel 1, 1 m.
(C) Lum-GFP vesicle delivery to the Flemming body (0’–30’, arrows) followed by signal loss (60’, at arrow) and abscission (80’ and 95’). Phase-
contrast images were taken after disappearance of GFP signal. Enlargements of Flemming body are shown to the right of each low-magnifica-
tion image in 70’–95’. Scale bar at 70’: 10 m for 0’–95’ and 2 m for enlargements in 70’–95’.
(D) Lum-GFP vesicle delivery to one side of the midbody (panels 1–3) followed by disappearance of the GFP signal (panel 4) and abscission
(loss of intercellular bridge, panels 5–7, arrows). The box in panel 5 is enlarged in panel 6. Solid and dotted lines show cell boundaries.
(E) Postmitotic cell (1) showing microtubules (green, GT335 antibody) of the intercellular bridge (phase-contrast image, inset) attached to one
of the two daughter cells; no detectable midbody microtubules are seen on the other cell. Microtubules are on both sides of the midbody
ring (arrow, red, MKLP-1) and Flemming body (inset, phase), showing that the midbody with attached microtubules was delivered to one
daughter cell. Prophase HeLa cell (2) with condensing chromatin (blue) and two centrosomes (green) has a midbody ring and lateral material
Secretory-Vesicle Machinery Mediates Abscission
83this idea, we used brefeldin A, which disrupts cytokine-
stained with MKLP-1 (arrow, red) and in enlargement (bottom right); the Flemming body with flanking material is enlarged at upper right.
Metaphase cell (3) with two midbody rings stained for MKLP-1 (red). Inset, two Flemming bodies corresponding to the two MKLP-1-stained
structures. Centrosomes, green; DNA, blue. Interphase cell (4) showing four MKLP-1-stained midbody rings (red). Two are enlarged in lower
inset and colocalize with phase-dense Flemming bodies (upper inset). DNA, blue; microtubules, green.
GFP-labeled secretory vesicles in Golgi complexes andprotein localized to the midbody ring at the same time
as the exocyst and shortly after centriolin (Figure 5A,
panel 2).
Previous immunofluorescence studies showed that
the v-SNARE endobrevin/VAMP8 and t-SNARE syn-
taxin-2 were enriched in the region of the midbody
flanking the Flemming body and coincident with micro-
tubules and Aurora B staining (Low et al., 2003). Using
the same antibodies, we confirmed the localization pat-
tern of endobrevin/VAMP8 (Figure 5A, panel 1) and syn-
taxin-2 (data not shown). Very late in cytokinesis, the
intercellular bridge narrows to w0.5 m, and microtu-
bule bundles are reduced in diameter to 0.2–0.5 m.
At this time, endobrevin/VAMP8 and syntaxin-2 joined
centriolin, snapin, and the exocyst at the midbody ring
(Figure 5A, panels 3 and 4). siRNA depletion of centrio-
lin eliminated the midbody-ring localization of snapin
(>35% of cells, Figure 5B), endobrevin/VAMP8 (>20%
of cells, Figure 5C), and syntaxin-2 (Figure 5C). Of the
remaining cells, 24% and 36% showed midbody stain-
ing levels below those of controls for snapin (n = 22)
and endobrevin/VAMP8 (n = 25), respectively. As shown
earlier, midbody-ring integrity was not compromised
under these conditions, as MKLP-1 and MgcRacGAP
remained at this site in cells with reduced centriolin.
These results indicated that centriolin was required for
midbody-ring localization of v- and t-SNARE proteins
and the SNARE-associated protein snapin.
Snapin Depletion Mislocalizes the Protein from the
Midbody and Induces Cytokinesis Defects
Midbodies in 41% of snapin-depleted cells showed no
detectable snapin staining (Figure 5D). Time-lapse
imaging over a 22 hr period showed that 40% of
snapin-depleted cells experienced late-stage cytokine-
sis failure (Figure 5E, Movie S4). Other cells showed
long delays and often remained connected by a thin
intercellular bridge (data not shown). When cultures
were imaged for an additional 24 hr, we observed multi-
cellular syncytia resulting from multiple incomplete divi-
sions and additional individual cells undergoing cytoki-
nesis failure. This suggested that most cells in the
population ultimately failed cytokinesis and that some
failed multiple times. Occasionally, cells separated
when one of the attached daughters re-entered mitosis,
possibly due to tensile forces generated by cell
rounding during mitosis (Figure 5E, Movie S4). These
results demonstrated that snapin was necessary for
abscission and suggested that it functioned by anchor-
ing SNARE complexes at the midbody.
Disruption of the Exocyst Results in Accumulation
of Secretory Vesicles at the Midbody
We next tested whether the late-stage cytokinesis de-
fects observed in this study resulted from changes in
membrane trafficking to the midbody. As a first test ofsis in C. elegans presumably due to inhibition of post-
Golgi secretory-vesicle trafficking (Skop et al., 2001). In
HeLa cells treated with brefeldin A, we observed late-
stage cytokinesis defects (Figure 6A) that were similar
to those observed following depletion of centriolin.
Many cells were delayed in or failed cytokinesis (n = 9/
13 cells in two separate experiments). This suggested
that post-Golgi vesicle trafficking was involved in late-
stage cytokinesis events in vertebrate cells, although
brefeldin A is known to affect other membrane-traffick-
ing pathways (Antonin et al., 2000).
Based on the localization of the exocyst to the mid-
body ring, we reasoned that the vesicle-tethering func-
tion of the complex might be operating at this site to
facilitate fusion of v-SNARE-containing vesicles at the
late stages of cytokinesis. To test this idea, we depleted
cells of sec5 to disrupt exocyst complexes and exam-
ined the localization of v-SNARE (endobrevin/VAMP8)
containing vesicles. We observed a collection of small,
spherical endobrevin/VAMP8-containing structures re-
sembling vesicles at the midbody (Figure 6B, panel 1,
arrows) that were positioned around the phase-dense
Flemming body (Figure 6B, arrowhead, panel 2). Al-
though these structures were occasionally seen in con-
trol lamin A/C siRNA-treated cells, they were signifi-
cantly increased in sec5-depleted cells (Figure 6B,
graph).
To determine whether the endobrevin/VAMP8-con-
taining structures were secretory vesicles, we used a
more specific marker for the secretory pathway. We ex-
pressed a GFP-tagged construct containing an amino-
terminal signal peptide that targets the protein to the
lumen of the ER (lum-GFP) (Blum et al., 2000) and lacks
retention and retrieval motifs, so it would not be ex-
pected to target to endosomes, multivesicular bodies,
or lysosomes. The lum-GFP was efficiently secreted
from nondividing MDCK cells following a 19°C trans-
Golgi network block and release from the block in the
presence of protein-synthesis inhibitors (C.Y., unpub-
lished data). When we expressed lum-GFP, numerous
GFP-containing vesicles were observed in the cyto-
plasm. Following fixation and staining for endobrevin/
VAMP8, we found that most of the endobrevin/VAMP8
vesicles colabeled with lum-GFP throughout the cyto-
plasm (Figure 6C) and within the intercellular bridge
during late stages of cytokinesis (Figure 6C, insets).
This observation demonstrates that the v-SNARE-con-
taining vesicles that accumulated following disruption
of the exocyst are secretory vesicles, an observation
similar to that seen in studies in exocyst mutants of S.
cerevisiae where vesicles dock normally but fail to fuse
with the plasma membrane (Guo et al., 2000)
Asymmetric Delivery of Secretory Vesicles
to the Midbody Is Followed by Abscission
At early stages of cytokinesis, we observed numerous
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84cell bodies of nascent daughter cells but few within in-
tercellular bridges (Figure 7A, panel 1). However, at a
late stage of cytokinesis when the intercellular bridge
narrowed to a diameter of w2 m and the midbody
microtubule bundle was reduced to a diameter of
0.5–1 m, GFP secretory vesicles accumulated in the
intercellular bridge near the midbody ring (Figure 7A,
Movie S5). Higher-magnification imaging of another cell
at a similar cell-cycle stage revealed labeled secretory
vesicles moving suddenly and rapidly (within 20 min)
from the cell bodies into the intercellular bridge and up
to the midbody ring (Figure 7B, Movie S6). In 11/11
cells, the vesicles were delivered primarily if not exclu-
sively from one of the nascent daughter cells (Figure
7B, center panels). Vesicles packed into the region ad-
jacent to the phase-dense Flemming body (Figure 7B,
panels 2 and 3, large arrowhead; Movie S6). Within 20
min, the GFP signal disappeared (Figure 7B, last panel
and Figure 7A, last panel), suggesting that the vesicles
fused with the plasma membrane, releasing the GFP
signal into the extracellular space where it was free to
diffuse. Loss of the GFP signal was not due to photo-
bleaching because GFP-labeled vesicles in cell bodies
adjacent to the intercellular bridge and in the Golgi
complex retained the signal. We next examined the re-
lationship between vesicle delivery to the midbody and
abscission. We found that, shortly after the GFP signal
was lost from the midbody region, the cell cleaved on
the side of the Flemming body that received the GFP
vesicles (6/6 cells from four experiments, Figure 7C).
The cell on the opposite side received the Flemming
body (Figure 7C, 70’–95’ and Figure 7D). In some cases,
the Flemming body moved around rapidly after abscis-
sion on the cell surface (Movie S7), suggesting that the
structure was not anchored at a discrete point on the
new daughter cell. Postdivision midbodies contained
multiple midbody-ring components and retained micro-
tubules from both sides of the midbody ring (Figure 7E,
panel 1). They persisted for some time after abscission,
consistent with previous results (Mishima et al., 2002),
and were often present in multiple copies, suggesting
that they were retained through several cell cycles (Fig-
ure 7E, panels 2–4). These structures were seen on
w35% of HeLa cells and often retained features of the
Flemming body and midbody ring, including MKLP-1
staining, Aurora B staining, phase-dense Flemming
bodies, and localization to the plasma membrane (Fig-
ure 7E, data not shown). This suggested that supernu-
merary midbodies represent structures from previous
divisions similar to the bud scars observed in yeast
(Chen and Contreras, 2004).
Discussion
A Model for the Final Stage of Cytokinesis
This study defines several distinct molecular and struc-
tural steps during the late stages of cytokinesis (Figure
8). During cleavage-furrow ingression, MKLP-1 and
MgcRacGAP arrive at the midbody ring (Figure 8A).
When the intercellular bridge forms, centriolin localizes
to the ring (Figure 8B), followed by snapin and exocyst
proteins (Figure 8C). When the diameter of the midbody
microtubule bundle and the intercellular bridge are
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aeduced to w0.5–1 m, endobrevin/VAMP8 (v-SNARE)
nd syntaxin-2 (t-SNARE) move to the midbody ring.
he v-SNAREs are part of secretory vesicles that move
symmetrically into the intercellular bridge predominantly
rom one nascent daughter cell; binding to v-SNAREs
ay incorporate t-SNAREs into this organization. The
esicles pack into the area adjacent to the ring and ap-
ear to fuse, releasing their contents into the extracel-
ular space (lum-GFP, Figures 8D and 8E). Vesicle fusion
ith the plasma membrane may be initiated near the
idbody ring where v- and t-SNAREs are localized.
his could be followed by additional fusion events be-
ween vesicles and the plasma membrane as well as
esicle-vesicle fusion events (homotypic) mediated by
NAP23/25, a v-SNARE involved in compound exo-
ytosis (Takahashi et al., 2004) (Figures 8F and 8G). Ab-
cission then occurs at the site of vesicle fusion, and
he entire midbody remains with the daughter cell op-
osite the fusion site (Figure 8H). Abscission could be
riggered by arrival of v- and t-SNAREs at the midbody
ing; release of SNAP23/25 from lipid rafts (Takahashi et
l., 2004; Takeda et al., 2004); phosphorylation of snapin
y PKA, which mediates its binding to the t-SNARE com-
lex (Buxton et al., 2003; Chheda et al., 2001); or another
vent. Dynamic movement of the postabscission mid-
ody ring suggests connections to motile forces within
he cell, although this remains to be determined.
symmetric Delivery of Secretory Vesicles Marks
he Site of Abscission
t is remarkable that secretory vesicles loaded with lu-
inal GFP move into the intercellular bridge from only
ne of the two prospective daughter cells. The mecha-
ism of this asymmetric vesicle delivery is unknown. It
s tempting to speculate that a signal, negative or posi-
ive, emanates asymmetrically from one centrosome in
he dividing cell. Centrosomes in the two prospective
aughter cells are different in that one was “born” from
he older centriole in the previous cell division during
he centrosome duplication process (Doxsey, 2001).
onsistent with this idea is the asymmetric spindle-
ole body (SPB) localization of budding- and fission-
east proteins that control mitotic exit and cytokinesis
Doxsey et al., 2005; Grallert et al., 2004; Molk et al.,
004). In S. pombe, inhibitors of mitotic exit (Cdc16p
nd Byr4p) localize to the “old” SPB while activators of
itotic exit (Cdc7p and presumably Sid1p and Cdc14p)
ocalize to the new SPB (Grallert et al., 2004). The rele-
ance of this localization in both yeasts is still un-
nown. Further studies will be required to determine
he role of centrosome protein asymmetry in the unidi-
ectional delivery of secretory vesicles and abscission
n animal cells. It has been suggested that the mother
entriole moves to the intercellular bridge in telophase
ells to coordinate the final steps in cytokinesis (Piel et
l., 2001), although this was not consistently observed
n this study (data not shown) or another that investi-
ated several cell lines (RPE-1, Ptk-1, CV-1, NRK-52E;
. Khodjakov, personal communication).
The final stages of cytokinesis in animal cells share
eatures with cell division in higher plants. Higher plant
ells cannot divide using an actomyosin-based cleav-
ge furrow due to the presence of a nonpliant cell wall,
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85Figure 8. Model Depicting Vesicle-Mediated Abscission during Cytokinesis
(See text for details.)
(A) MKLP-1 and MgcRacGAP (green) arrive at midbody ring after cleavage furrowing has progressed. Microtubules, brown; plasma membrane,
upper and lower lines.
(B and C) Centriolin moves to ring ([B], blue) and anchors sec15, other exocyst components, and snapin ([C], red).
(D) When midbody microtubules are reduced and the membrane constricted, v- and t-SNAREs ([D], black) move to the midbody ring from
one prospective daughter cell. v-SNAREs presumably move with vesicles and bind there in a centriolin-dependent manner; t-SNAREs on the
plasma membrane could bind through v-SNAREs.
(E) Vesicles heterogeneous in diameter pack asymmetrically into the intercellular bridge adjacent to the midbody ring.
(F and G) Vesicles adjacent to the ring containing SNARES and exocyst fuse with the plasma membrane (F) as well as at other plasma-
membrane sites and with one another (G).
(H) Abscission follows at the site of membrane fusion, and the midbody is retained by the daughter cell opposite the fusion site. The released
midbody ring contains multiple midbody-ring proteins and usually retains microtubule bundles from both sides of the ring. (In this model, the
apparent “layering” of components is a simplification to depict arrival of different components at the midbody.)so they accomplish cell division by constructing a new
membrane at the division plane, called the cell plate,
that is independent of the plasma membrane and is
established by microtubule-dependent delivery and fu-
sion of vesicles at this site (Albertson et al., 2005; Fin-
ger and White, 2002; Jurgens, 2005). Our data show
that the coordinated delivery of vesicles to the midbody
ring during the late stages of cytokinesis is also re-
quired for the final stages of cell division in animal cells.
However, we still do not understand the mechanism of
secretory-vesicle delivery to the midbody, the role of
microtubules in this process, or the precise contribu-
tion of vesicle transport and fusion to abscission. The
presence of vesicles with heterogeneous diameters ad-
jacent to the midbody ring prior to abscission is consis-
tent with a model in which some vesicles fuse together
prior to fusion with the plasma membrane. This would
be analogous to the cell plate in plant cells. The enodo-
cytic pathway also appears to play a role in cell cleav-
age as components (dynamin, FIP3, Rab11) and com-
partments (endosomes) involved in this pathway affect
the late stages of cytokinesis (Thompson et al., 2002;
Wilson et al., 2005). Recycling endosomes have been
shown to move from both prospective daughter cells
to the midbody during cytokinesis then return to the
daughter-cell cytoplasm (Wilson et al., 2005). It is stillunclear how recycling endosomes participate in ab-
scission and how the bidirectional movement of endo-
somes into the intercellular bridge is related to the uni-
directional movement of secretory vesicles to this site
in our study.
Structure and Persistence of the Midbody Ring
We have shown that many proteins localize to the mid-
body ring and that the phase-dense Flemming body is
also organized into the shape of a ring. This is consis-
tent with earlier ultrastructural studies that describe cy-
toplasmic channels coursing through the central mid-
body (Mullins and Biesele, 1977). The ring structure
bears a resemblance to bud scars of S. cerevisiae,
which serve as markers for longevity (Chen and Con-
treras, 2004). The midbody ring in animal cells is inher-
ited by the daughter cell that lies opposite the site of
vesicle delivery and appears to persist, as it is often
seen in mitotic cells prior to cytokinesis and found in
multiple copies in interphase cells (Figure 7E) (Mishima
et al., 2002). Shortly after abscission, the midbody ring
contains microtubules that extend from both sides of
the ring. This suggests that dissolution of microtubule
bundles adjacent to the midbody ring is not an absolute
requirement for the final stage of cytokinesis but rather
that abscission can result in transfer of the entire mid-
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86body and associated microtubules into one daughter
cell.
Experimental Procedures
Cell Culture and Transfections
The cells used primarily in this study were diploid, telomerase-im-
mortalized human RPE cells (hTERT-RPE-1s, Clontech Laborato-
ries, Inc.) (Morales et al., 1999) and HeLa cells. All cells were grown
as previously described (American Type Culture Collection). HeLa
cells were transfected as previously described (Lipofectamine, Invi-
trogen).
Immunofluorescence
Cells were prepared for immunofluorescence, imaged, and decon-
volved (Metamorph, Universal Imaging Corp.) using either formal-
dehyde, formaldehyde followed by methanol, or methanol alone as
previously described (Dictenberg et al., 1998). All immunofluores-
cence images are two-dimensional projections of three-dimen-
sional reconstructions to ensure that all stained material was visi-
ble in two-dimensional images. Quantification of signals produced
by immunofluorescence staining for various midbody antigens was
performed as described for centrosome protein quantification in
our earlier studies (Gromley et al., 2003).
Antibodies
Antibodies to the following proteins were used: sec3, sec5, sec8,
sec10, exo70, exo84, and sec15 (Yeaman, 2003); centriolin (Grom-
ley et al., 2003); α-tubulin, γ-tubulin, α-His6, and α-myc (Sigma-
Aldrich); Aurora B (Transduction Laboratories); MKLP-1, GAL4
transactivation domain (AD), and GAL4 DNA binding domain (DBD)
(Santa Cruz Biotechnology, Inc.); and GT335 for stabilized microtu-
bules (Gromley et al., 2003).
Yeast Two-Hybrid Screen
Yeast two-hybrid library screens were performed following the
manufacturer’s instructions using a human testis Matchmaker Pre-
Transformed Two-Hybrid Library (Matchmaker GAL4 Yeast Two-
Hybrid System, Clontech). False positives were eliminated by mat-
ing each clone with strains expressing either lamin C or the DNA
binding domain alone and plating on quadruple dropout media.
siRNAs
Two siRNAs targeting centriolin and one targeting lamin A/C were
used as described (Gromley et al., 2003). Additional siRNAs tar-
geted nucleotides in the following proteins: MKLP-1 (189–207),
sec5 (260–278), sec8 (609–627), and snapin (312–330). Cells were
examined 24–48 hr after siRNA treatment. siRNAs were used at
10–50 nM, and Lipofectamine was the delivery agent (Gromley et
al., 2003).
Brefeldin A Treatment
HeLa cells were treated with 5–10 g/ml brefeldin A (Sigma-Aldrich)
and imaged.
Immunoprecipitations
Antibodies to centriolin or exocyst were added to hTERT-RPE cell
extracts and incubated at 4°C overnight. The lysis buffer included
50 mM Tris-HCl (pH 7.5), 10 mM Na2HPO4 (pH 7.2), 1 mM EDTA,
150 mM NaCl, 1% IGEPAL CA-1630, and protease inhibitors (Mini
tablets, Roche Diagnostics, Mannheim, Germany). Superose 6 sam-
ples were incubated with antibodies to sec3 and sec8, bound to
protein A/G beads (Santa Cruz Biotechnology, Inc.) at 4°C for 2 hr
(Yeaman, 2003), and exposed to SDS-PAGE and immunoblotting
(Harlow and Lane, 1988).
Time-Lapse Imaging
Time-lapse imaging of cytokinesis was performed using a wide-
field microscope (Gromley et al., 2003), and images were taken ev-
ery 5 min for 18–24 hr. For luminal-GFP-expressing cells (Figure
7B), two concurrent time-lapse programs were used (GFP, phase
contrast), and images were taken every 2 min for 3–4 hr. A Perki-
nElmer spinning-disc confocal microscope with an UltraVIEW CSU-
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M0 head was used for Figures 7A, 7C, and 7D. Images were taken
very 5 min and captured on an ORCA-AG cooled CCD camera.
mages of GFP-GAPCenA-expressing cells were taken every 10 min
n a Zeiss Axiophot microscope equipped with a Hamamatsu digi-
al camera. Mitochondria function was assessed by Mitotracker
taining (Molecular Probes).
xocyst Fractionation
or isopycnic centrifugation, membrane compartments containing
xocyst fractions were prepared as described (Grindstaff et al.,
998; Yeaman, 2003). For size-exclusion chromatography, cells
ere extracted with MEBC buffer (0.5% Nonidet P-40, 50 mM Tris-
Cl [pH 7.5], 100 mM NaCl) containing protease inhibitors (0.1 mM
a3VO4; 50 mM NaF; 1 mM Pefabloc [Boehringer Mannheim]; and
0 g/ml each of leupeptin, antipain, chymostatin, and pepstatin
) for 10 min at 4°C. Lysates were first sedimented in a Microfuge
Beckman Instruments, Fullerton, California) for 10 min and then for
0 min at 100,000 × g, passed through a 0.22 m filter (Millipore),
nd loaded on a Superose 6 HR 10/30 column (200 l, 10 mm × 30
m; Pharmacia Biotech, Inc.) equilibrated in MEBC buffer and 1
M dithiothreitol with 0.1 mM Pefabloc. Proteins were eluted (0.3
l/min) at 17°C in 0.5 ml fractions, the concentration of protein in
he fractions was determined, and the fractions were used for vari-
us assays (fractions 7–30).
upplemental Data
upplemental Data include one figure and seven movies and can
e found with this article online at http://www.cell.com/cgi/content/
ull/123/1/75/DC1/.
cknowledgments
e thank Dan McCollum, Yu-Li Wang, Ted Salmon, and Bill Theur-
auf for useful discussions. We thank Z. Sheng (NINDS, NIH)
snapin), T. Wiembs (Lerner Institute, Cleveland) (endobrevin/
AMP8 and syntaxin-2) and M. Glotzer (IMP, Vienna) (MKLP-1,
gcRacGAP) for antibodies. This work was supported in part by
rants from the National Institutes of Health to S.J.D. (GM51994)
nd from the Department of Defense to C.Y. (DAMD-17-03-1-0187).
eceived: August 18, 2004
evised: June 3, 2005
ccepted: July 27, 2005
ublished: October 6, 2005
eferences
lbertson, R., Riggs, B., and Sullivan, W. (2005). Membrane traffic:
driving force in cytokinesis. Trends Cell Biol. 15, 92–101.
ntonin, W., Holroyd, C., Tikkanen, R., Honing, S., and Jahn, R.
2000). The R-SNARE endobrevin/VAMP-8 mediates homotypic fu-
ion of early endosomes and late endosomes. Mol. Biol. Cell 11,
289–3298.
lum, R., Stephens, D.J., and Schulz, I. (2000). Lumenal targeted
FP, used as a marker of soluble cargo, visualises rapid ERGIC to
olgi traffic by a tubulo-vesicular network. J. Cell Sci. 113, 3151–
159.
uxton, P., Zhang, X.M., Walsh, B., Sriratana, A., Schenberg, I.,
anickam, E., and Rowe, T. (2003). Identification and characteriza-
ion of Snapin as a ubiquitously expressed SNARE-binding protein
hat interacts with SNAP23 in non-neuronal cells. Biochem. J. 375,
33–440.
hen, C., and Contreras, R. (2004). The bud scar-based screening
ystem for hunting human genes extending life span. Ann. N Y
cad. Sci. 1019, 355–359.
hheda, M.G., Ashery, U., Thakur, P., Rettig, J., and Sheng, Z.H.
2001). Phosphorylation of Snapin by PKA modulates its interaction
ith the SNARE complex. Nat. Cell Biol. 3, 331–338.
uif, M.H., Possmayer, F., Zander, H., Bordes, N., Jollivet, F.,
ouedel-Courteille, A., Janoueix-Lerosey, I., Langsley, G., Bornens,
., and Goud, B. (1999). Characterization of GAPCenA, a GTPase
Secretory-Vesicle Machinery Mediates Abscission
87activating protein for Rab6, part of which associates with the cen-
trosome. EMBO J. 18, 1772–1782.
Dictenberg, J., Zimmerman, W., Sparks, C., Young, A., Vidair, C.,
Zheng, Y., Carrington, W., Fay, F., and Doxsey, S.J. (1998). Peri-
centrin and gamma tubulin form a protein complex and are orga-
nized into a novel lattice at the centrosome. J. Cell Biol. 141, 163–
174.
Dobbelaere, J., and Barral, Y. (2004). Spatial coordination of cytoki-
netic events by compartmentalization of the cell cortex. Science
305, 393–396.
Doxsey, S. (2001). Re-evaluating centrosome function. Nat. Rev.
Mol. Cell Biol. 2, 688–698.
Doxsey, S., McCollum, D., and Theurkauf, W. (2005). Centrosomes
in cellular regulation. Annu. Rev. Cell Dev. Biol. 21, 688–698. in
press.
Echard, A., Hickson, G.R., Foley, E., and O’Farrell, P.H. (2004). Ter-
minal cytokinesis events uncovered after an RNAi screen. Curr.
Biol. 14, 1685–1693.
Finger, F.P., and White, J.G. (2002). Fusion and fission: membrane
trafficking in animal cytokinesis. Cell 108, 727–730.
Finger, F.P., Hughes, T.E., and Novick, P. (1998). Sec3p is a spatial
landmark for polarized secretion in budding yeast. Cell 92, 559–
571.
Glotzer, M. (2001). Animal cell cytokinesis. Annu. Rev. Cell Dev. Biol.
17, 351–386.
Glotzer, M. (2005). The molecular requirements for cytokinesis. Sci-
ence 307, 1735–1739.
Grallert, A., Krapp, A., Bagley, S., Simanis, V., and Hagan, I.M.
(2004). Recruitment of NIMA kinase shows that maturation of the
S. pombe spindle-pole body occurs over consecutive cell cycles
and reveals a role for NIMA in modulating SIN activity. Genes Dev.
18, 1007–1021.
Grindstaff, K.K., Yeaman, C., Anandasabapathy, N., Hsu, S.C., Ro-
driguez-Boulan, E., Scheller, R.H., and Nelson, W.J. (1998). Sec6/8
complex is recruited to cell-cell contacts and specifies transport
vesicle delivery to the basal-lateral membrane in epithelial cells.
Cell 93, 731–740.
Gromley, A., Jurczyk, A., Sillibourne, J., Halilovic, E., Mogensen, M.,
Groisman, I., Blomberg, M., and Doxsey, S. (2003). A novel human
protein of the maternal centriole is required for the final stages of
cytokinesis and entry into S phase. J. Cell Biol. 161, 535–545.
Guertin, D.A., Trautmann, S., and McCollum, D. (2002). Cytokinesis
in eukaryotes. Microbiol. Mol. Biol. Rev. 66, 155–178.
Guo, W., Sacher, M., Barrowman, J., Ferro-Novick, S., and Novick,
P. (2000). Protein complexes in transport vesicle targeting. Trends
Cell Biol. 10, 251–255.
Harlow, E., and Lane, D. (1988). Antibodies: A Laboratory Manual
(Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
Jurgens, G. (2005). Plant cytokinesis: fission by fusion. Trends Cell
Biol. 15, 277–283.
Low, S.H., Li, X., Miura, M., Kudo, N., Quinones, B., and Weimbs,
T. (2003). Syntaxin 2 and endobrevin are required for the terminal
step of cytokinesis in mammalian cells. Dev. Cell 4, 753–759.
Mishima, M., Kaitna, S., and Glotzer, M. (2002). Central spindle as-
sembly and cytokinesis require a kinesin-like protein/RhoGAP
complex with microtubule bundling activity. Dev. Cell 2, 41–54.
Molk, J.N., Schuyler, S.C., Liu, J.Y., Evans, J.G., Salmon, E.D., Pell-
man, D., and Bloom, K. (2004). The differential roles of budding
yeast Tem1p, Cdc15p, and Bub2p protein dynamics in mitotic exit.
Mol. Biol. Cell 15, 1519–1532.
Mondesert, G., Clarke, D.J., and Reed, S.I. (1997). Identification of
genes controlling growth polarity in the budding yeast Saccharo-
myces cerevisiae: a possible role of N-glycosylation and involve-
ment of the exocyst complex. Genetics 147, 421–434.
Monzo, P., Gauthier, N.C., Keslair, F., Loubat, A., Field, C.M., Le
Marchand-Brustel, Y., and Cormont, M. (2005). Clues to CD2-asso-
ciated protein involvement in cytokinesis. Mol. Biol. Cell 16, 2891–
2902. 10.1091/mbc.E04-09-0773
Morales, C.P., Holt, S.E., Ouellette, M., Kaur, K.J., Yan, Y., Wilson,K.S., White, M.A., Wright, W.E., and Shay, J.W. (1999). Absence of
cancer-associated changes in human fibroblasts immortalized with
telomerase. Nat. Genet. 21, 115–118.
Mullins, J.M., and Biesele, J.J. (1977). Terminal phase of cytokinesis
in D-98s cells. J. Cell Biol. 73, 672–684.
Murthy, M., and Schwarz, T.L. (2004). The exocyst component Sec5
is required for membrane traffic and polarity in the Drosophila
ovary. Development 131, 377–388.
Papoulas, O., Hays, T.S., and Sisson, J.C. (2004). The golgin Lava
lamp mediates dynein-based Golgi movements during Drosophila
cellularization. Nat. Cell Biol. 7, 612–618. 10.1038/ncb1264
Paweletz, N. (1967). On the function of the ‘Flemming body’ during
division of animal cells. Naturwissenschaften 54, 533–535.
Piel, M., Nordberg, J., Euteneuer, U., and Bornens, M. (2001). Cen-
trosome-dependent exit of cytokinesis in animal cells. Science 291,
1550–1553.
Prigent, M., Dubois, T., Raposo, G., Derrien, V., Tenza, D., Rosse, C.,
Camonis, J., and Chavrier, P. (2003). ARF6 controls post-endocytic
recycling through its downstream exocyst complex effector. J. Cell
Biol. 163, 1111–1121.
Salminen, A., and Novick, P.J. (1989). The Sec15 protein responds
to the function of the GTP binding protein, Sec4, to control vesicu-
lar traffic in yeast. J. Cell Biol. 109, 1023–1036.
Saxton, W.M., and McIntosh, J.R. (1987). Interzone microtubule be-
havior in late anaphase and telophase spindles. J. Cell Biol. 105,
875–886.
Skop, A.R., Bergmann, D., Mohler, W.A., and White, J.G. (2001).
Completion of cytokinesis in C. elegans requires a brefeldin A-sen-
sitive membrane accumulation at the cleavage furrow apex. Curr.
Biol. 11, 735–746.
Skop, A.R., Liu, H., Yates, J., Meyer, B.J., and Heald, R. (2004).
Dissection of the mammalian midbody proteome reveals con-
served cytokinesis mechanisms. Science 305, 61–66. Published
online May 27, 2004..
Strickland, L.I., and Burgess, D.R. (2004). Pathways for membrane
trafficking during cytokinesis. Trends Cell Biol. 14, 115–118.
Takahashi, N., Hatakeyama, H., Okado, H., Miwa, A., Kishimoto, T.,
Kojima, T., Abe, T., and Kasai, H. (2004). Sequential exocytosis of
insulin granules is associated with redistribution of SNAP25. J. Cell
Biol. 165, 255–262.
Takeda, T., Kawate, T., and Chang, F. (2004). Organization of a ste-
rol-rich membrane domain by cdc15p during cytokinesis in fission
yeast. Nat. Cell Biol. 6, 1142–1144.
Thakur, P., Stevens, D.R., Sheng, Z.H., and Rettig, J. (2004). Effects
of PKA-mediated phosphorylation of Snapin on synaptic transmis-
sion in cultured hippocampal neurons. J. Neurosci. 24, 6476–6481.
Thompson, H.M., Skop, A.R., Euteneuer, U., Meyer, B.J., and McNi-
ven, M.A. (2002). The large GTPase dynamin associates with the
spindle midzone and is required for cytokinesis. Curr. Biol. 12,
2111–2117.
Verplank, L., and Li, R. (2005). Cell cycle-regulated trafficking of
Chs2 controls actomyosin ring stability during cytokinesis. Mol.
Biol. Cell 16, 2529–2543.
Vites, O., Rhee, J.S., Schwarz, M., Rosenmund, C., and Jahn, R.
(2004). Reinvestigation of the role of snapin in neurotransmitter re-
lease. J. Biol. Chem. 279, 26251–26256.
Wang, H., Tang, X., Liu, J., Trautmann, S., Balasundaram, D.,
McCollum, D., and Balasubramanian, M.K. (2002). The multiprotein
exocyst complex is essential for cell separation in Schizosaccharo-
myces pombe. Mol. Biol. Cell 13, 515–529.
Wilson, G.M., Fielding, A.B., Simon, G.C., Yu, X., Andrews, P.D.,
Hames, R.S., Frey, A.M., Peden, A.A., Gould, G.W., and Prekeris, R.
(2005). The FIP3-Rab11 protein complex regulates recycling endo-
some targeting to the cleavage furrow during late cytokinesis. Mol.
Biol. Cell 16, 849–860.
Yeaman, C. (2003). Ultracentrifugation-based approaches to study
regulation of Sec6/8 (exocyst) complex function during develop-
ment of epithelial cell polarity. Methods 30, 198–206.
Yeaman, C., Grindstaff, K.K., and Nelson, W.J. (2004). Mechanism
of recruiting Sec6/8 (exocyst) complex to the apical junctional com-
plex during polarization of epithelial cells. J. Cell Sci. 117, 559–570.
